Identification and validation of a novel overall survival prediction model for immune-related genes in bone metastases of prostate cancer
Figure 5.The nomogram of the OS predictive model for 1, 3, and 5 years. Nomogram and calibration plot for predicting 1, 3, and 5 years OS model in the training (A) and validation (B) cohorts.